Cargando…

USH2A Mutation is Associated With Tumor Mutation Burden and Antitumor Immunity in Patients With Colon Adenocarcinoma

Colon adenocarcinoma (COAD) is one of the diseases with the highest morbidity and mortality in the world. At present, immunotherapy has become a valuable method for the treatment of COAD. Tumor mutational burden (TMB) is considered to be the most common biomarker for predicting immunotherapy. Accord...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yuanyuan, Li, Long, Yao, Wenchao, Liu, Xuxu, Yang, Yang, Ma, Biao, Xue, Dongbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593250/ https://www.ncbi.nlm.nih.gov/pubmed/34795697 http://dx.doi.org/10.3389/fgene.2021.762160

Ejemplares similares

Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients
por: Peng, Linglong, et al.
Publicado: (2021)

Mutational screening of the USH2A gene in Spanish USH patients reveals 23 novel pathogenic mutations
por: Garcia-Garcia, Gema, et al.
Publicado: (2011)

Genetic instability-related lncRNAs predict prognosis and influence the immune microenvironment in breast cancer
por: Lv, Zhenyi, et al.
Publicado: (2022)

Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer
por: Zhou, Zhangjian, et al.
Publicado: (2021)

Novel Missense and Splice Site Mutations in USH2A, CDH23, PCDH15, and ADGRV1 Are Associated With Usher Syndrome in Lebanon
por: Jaffal, Lama, et al.
Publicado: (2022)

Case report: Disease phenotype associated with simultaneous biallelic mutations in ABCA4 and USH2A due to uniparental disomy of chromosome 1
por: Villafuerte-De la Cruz, R., et al.
Publicado: (2022)

Novel USH2A compound heterozygous mutations cause RP/USH2 in a Chinese family
por: Liu, Xiaowen, et al.
Publicado: (2010)

Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma
por: Ouyang, Rong, et al.
Publicado: (2021)

miRNA-Based Signature Associated With Tumor Mutational Burden in Colon Adenocarcinoma
por: Xue, Weijie, et al.
Publicado: (2021)

Genetic Characteristics and Variation Spectrum of USH2A-Related Retinitis Pigmentosa and Usher Syndrome
por: Li, Wei, et al.
Publicado: (2022)

Significance of Tumor Mutation Burden Combined With Immune Infiltrates in the Progression and Prognosis of Advanced Gastric Cancer
por: Guo, Xiong, et al.
Publicado: (2021)

Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Signature for Ovarian Cancers
por: Cui, Mengjing, et al.
Publicado: (2022)

Mutations in lysine methyltransferase 2C and PEG3 are associated with tumor mutation burden, prognosis, and antitumor immunity in pancreatic adenocarcinoma patients
por: Huang, Yili, et al.
Publicado: (2022)

MDN1 Mutation Is Associated With High Tumor Mutation Burden and Unfavorable Prognosis in Breast Cancer
por: Hao, Shuai, et al.
Publicado: (2022)

A Prognostic Model for Predicting Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Bladder Urothelial Carcinoma
por: Wang, Chengbang, et al.
Publicado: (2022)

Association of a Novel Prognosis Model with Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Thyroid Carcinoma
por: Zhang, Siqin, et al.
Publicado: (2021)

Association of MSH2 Expression With Tumor Mutational Burden and the Immune Microenvironment in Lung Adenocarcinoma
por: Jia, Mingming, et al.
Publicado: (2020)

Novel mutations in the USH1C gene in Usher syndrome patients
por: Aparisi, María José, et al.
Publicado: (2010)

Identification of Novel Prognostic Biomarkers Relevant to Immune Infiltration in Lung Adenocarcinoma
por: Xia, Zhi, et al.
Publicado: (2022)

Mutation screening of the USH2A gene in retinitis pigmentosa and USHER patients in a Han Chinese population
por: Huang, Lulin, et al.
Publicado: (2018)

EP300 mutation is associated with tumor mutation burden and promotes antitumor immunity in bladder cancer patients
por: Zhu, Gongmin, et al.
Publicado: (2020)

Titin Mutation Is Associated With Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Squamous Cell Carcinoma
por: Xie, Xiaona, et al.
Publicado: (2021)

p53 mutation and deletion contribute to tumor immune evasion
por: Liu, Siyang, et al.
Publicado: (2023)

Identification and Validation of Immune-Related Prognostic Genes in the Tumor Microenvironment of Colon Adenocarcinoma
por: Pan, Shenghua, et al.
Publicado: (2022)

A Joint Model Considering Measurement Errors for Optimally Identifying Tumor Mutation Burden Threshold
por: Wang, Yixuan, et al.
Publicado: (2022)

Novel mutations of the USH2A gene cause Usher syndrome in five Chinese families
por: Xing, Dongjun, et al.
Publicado: (2022)

Fucosyltransferases Regulated by Fusobacterium Nucleatum and Act as Novel Biomarkers in Colon Adenocarcinoma
por: Wang, Pengfei, et al.
Publicado: (2023)

Ferroptosis-Related Genes in Lung Adenocarcinoma: Prognostic Signature and Immune, Drug Resistance, Mutation Analysis
por: Ren, Ziyuan, et al.
Publicado: (2021)

A Ferroptosis-Related Prognostic Signature Based on Antitumor Immunity and Tumor Protein p53 Mutation Exploration for Guiding Treatment in Patients With Head and Neck Squamous Cell Carcinoma
por: Fan, Xin, et al.
Publicado: (2021)

CD1B is a Potential Prognostic Biomarker Associated with Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Adenocarcinoma
por: Li, Zhou, et al.
Publicado: (2022)

Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis
por: Ruan, Guo-Tian, et al.
Publicado: (2022)

USH2A Gene Mutations in Rabbits Lead to Progressive Retinal Degeneration and Hearing Loss
por: Nguyen, Van Phuc, et al.
Publicado: (2023)

Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma
por: Wang, Hao, et al.
Publicado: (2021)

Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
por: Peng, Ying-Peng, et al.
Publicado: (2021)

The nomogram based on the 6-lncRNA model can promote the prognosis prediction of patients with breast invasive carcinoma
por: Luo, Dankun, et al.
Publicado: (2021)

Glycolysis Changes the Microenvironment and Therapeutic Response Under the Driver of Gene Mutation in Esophageal Adenocarcinoma
por: Zhu, Lei, et al.
Publicado: (2021)

Development of an exosome-related and immune microenvironment prognostic signature in colon adenocarcinoma
por: Cui, Guoliang, et al.
Publicado: (2022)

Correlation of tumor mutational burden with prognosis and immune infiltration in lung adenocarcinoma
por: Li, Lin, et al.
Publicado: (2023)

Association of a Novel DOCK2 Mutation-Related Gene Signature With Immune in Hepatocellular Carcinoma
por: Huang, Yushen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oleg5mqgvd6n07f0vr2jlgdqtc